C12Y 101/01102
3-dehydrosphinganine reductase
Official title: 3-Dehydrosphinganine reductase (1.1.1.102)
C12Y101/01102 (3-dehydrosphinganine reductase) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 4
- Inventors
- 13
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Targeting 3-ketodihydrosphingosine reductase (kdsr) in cancer17 Oct 2024US 2024/0342255 A1University of Massachusetts
- Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipids15 Sep 2022US 2022/0288004 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Method for producing sphingoid base or sphingolipid28 Jun 2018US 2018/0179563 A1Ajinomoto Co., Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.